This metabolic regulatory role for CNP widens the critical cardio- and vasoprotective assignments of the peptide and heightens the therapeutic potential of drugs targeting CNP signaling in cardiovascular disease, including those associated with metabolic dysfunction. This evidence concerns the gene CNP and cardiovascular disorder.